Definium Therapeutics CFO Brandi Roberts Sells $123K of Stock
Brandi Roberts, CFO, sold 3,377 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $123K in total on Sep 25, 2026. Shares held after the trade: 394,528 (-0.8%).
Definium Therapeutics CLO Mark Sullivan Sells $514K of Stock
Mark Sullivan, CLO, sold 14,051 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $514K in total on Sep 25, 2026. Shares held after the trade: 494,228 (-2.8%).
Definium Therapeutics Chief Commercial Officer Matthew T. Wiley Sells $113K of Stock
Matthew T. Wiley, Chief Commercial Officer, sold 3,097 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $113K in total on Sep 25, 2026. Shares held after the trade: 359,036 (-0.9%).
Definium Therapeutics CEO Robert Barrow Sells $1.15M of Stock
Robert Barrow, CEO, sold 31,550 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $1.15M in total on Sep 25, 2026. Shares held after the trade: 2,213,090 (-1.4%).
Definium Therapeutics CMO Daniel Karlin Sells $397K of Stock
Daniel Karlin, CMO, sold 10,853 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $397K in total on Sep 25, 2026. Shares held after the trade: 792,846 (-1.4%).